As reported to coloplast, though not verified, between 10/2017-9/4/2018: uti, bladder pain, urinary hesitancy, vaginal itching, urinary frequency, urine culture showed >100,000 cfu/ml escherichia coli and 25-50,000 cfu/ml mixed gram positive/gram negative flora, pelvic and flank pain, pelvic floor dysfunction, bladder spasms, impaired sleep, urethral pain, urine culture showed 25-50,000 cfu/ml klebsiella pneumoniae, urinary incontinence, postoperative hemorrhage of vagina following genitourinary procedure, pelvic floor dysfunction, vaginal pain, mid to lower back pain, scar tissue, moderate detrusor instability, intrinsic sphincteric deficiency, cutting sensation in vagina and near urethra, nocturia, urinary urgency, urine culture showed >100,000 cfu/ml escherichia coli.Ua showed 1+ blood and leukocyte esterase, 12 wbc and + bacteria.On (b)(6) 2018 altis sling removal, urethral lysis, anterior colporrhaphy, vaginal paravaginal, removal of mesh from obturator internus muscles, removal of exposed ethibond from the posterior vaginal wall and gortex from the vaginal apex, and release of vaginal septum under general anesthesia for vaginal pain, urethral pain, pain with intercourse, foreign material in vagina and in pelvic muscles, scarring, rectocele, and cystocele.Pathology showed fibrosis, chronic inflammation, and foreign body giant cell reaction surrounding polarizable foreign material, compatible with mesh.Old tissue discharge, needle poking pain in vagina, pelvic derangement, pressure in vagina, pelvic floor weakness.No other adverse patient effects were reported.
|